Contact
searchSearch
HMP Global

Psoriatic Arthritis Topic Center

Featured

News
Deucravacitinib Improves Fatigue and Quality of Life in Psoriatic Arthritis, Phase 3 Pooled Analysis Shows
04/01/2026
Riya Gandhi, MA
Significant gains in physical, mental, and social functioning highlight the drug’s impact beyond joint symptoms.
Significant gains in physical, mental, and social functioning highlight the drug’s impact beyond joint symptoms.
Significant gains in physical,...
04/01/2026
The Dermatologist
News
Bimekizumab Demonstrates Sustained 3-Year Efficacy Across Joint, Skin, and Nail Domains in Psoriatic Arthritis
03/31/2026
Riya Gandhi, MA
Phase 3 data show durable responses and consistent safety in both biologic-naïve and TNFi-experienced patients with PsA and psoriasis.
Phase 3 data show durable responses and consistent safety in both biologic-naïve and TNFi-experienced patients with PsA and psoriasis.
Phase 3 data show durable...
03/31/2026
The Dermatologist
psoriatic arthritis
News
Risankizumab Maintains Radiographic Nonprogression Through 5 Years in Psoriatic Arthritis
03/30/2026
Riya Gandhi, MA
Five-year data from the phase 3 KEEPsAKE 1 trial show that risankizumab maintains low rates of radiographic progression in patients with active psoriatic arthritis.
Five-year data from the phase 3 KEEPsAKE 1 trial show that risankizumab maintains low rates of radiographic progression in patients with active psoriatic arthritis.
Five-year data from the phase 3...
03/30/2026
The Dermatologist
wells
Clinical Insights
Addressing Unmet Needs in Psoriatic Arthritis: Diagnosis, Pathogenesis, and Newer/Emerging Oral Therapies
03/02/2026
Hermon Feron, BA; Victoria Garfinkel, BSA
Dr Wells delivered a forward-thinking discussion on psoriatic arthritis, emphasizing that up to 30% of patients with psoriasis develop PsA and reinforcing that psoriasis is a systemic inflammatory.
Dr Wells delivered a forward-thinking discussion on psoriatic arthritis, emphasizing that up to 30% of patients with psoriasis develop PsA and reinforcing that psoriasis is a systemic inflammatory.
Dr Wells delivered a...
03/02/2026
The Dermatologist
psoriatic arthritis
News
Rare Case Highlights Diagnostic and Treatment Challenges in PsA–Myopathy Overlap
09/02/2025
Jessica Garlewicz
The case study, accompanied by a review of 17 similar reports, details shared immunopathogenesis and conflicting treatment responses in this rare overlap syndrome.
The case study, accompanied by a review of 17 similar reports, details shared immunopathogenesis and conflicting treatment responses in this rare overlap syndrome.
The case study, accompanied by a...
09/02/2025
The Dermatologist
psoriatic arthritis
News
Real-World Data Support ITABIO Guidelines for Second-Line Biologic Use in Inflammatory Arthritis
09/02/2025
Jessica Garlewicz
The study evaluated treatment patterns and patient characteristics to assess the impact of these guidelines in real-world care.
The study evaluated treatment patterns and patient characteristics to assess the impact of these guidelines in real-world care.
The study evaluated treatment...
09/02/2025
The Dermatologist
psoriatic arthritis
News
Integrated PsA Screening Framework Improves Outcomes in Dermatology Clinics
08/14/2025
Jessica Garlewicz
The study highlights a scalable clinical model that integrates validated screening tools into routine dermatologic care.
The study highlights a scalable clinical model that integrates validated screening tools into routine dermatologic care.
The study highlights a scalable...
08/14/2025
The Dermatologist
psoriatic arthritis
News
Study Finds Higher Fertility Rates Among Men With Inflammatory Joint Disease
08/14/2025
Jessica Garlewicz
A nationwide cohort study from Norway challenges assumptions about reproductive health in men with inflammatory joint diseases.
A nationwide cohort study from Norway challenges assumptions about reproductive health in men with inflammatory joint diseases.
A nationwide cohort study from...
08/14/2025
The Dermatologist
psoriatic arthritis
News
TNF Inhibitors Improve Clinical Outcomes in csDMARD-Inadequate Psoriatic Arthritis, Review Finds
07/22/2025
Jessica Garlewicz
For practicing dermatologists, these findings reinforce current guidelines that position TNF inhibitors as a first-line biologic option for patients with active psoriatic arthritis.
For practicing dermatologists, these findings reinforce current guidelines that position TNF inhibitors as a first-line biologic option for patients with active psoriatic arthritis.
For practicing dermatologists,...
07/22/2025
The Dermatologist
psoriatic arthritis
News
IL-23/IL-17 Axis Central to Psoriatic Arthritis Pathogenesis, Study Finds
07/10/2025
Jessica Garlewicz
Targeted intervention at the level of the IL-23/IL-17 axis may not only control clinical symptoms but also interrupt disease progression and systemic inflammation.
Targeted intervention at the level of the IL-23/IL-17 axis may not only control clinical symptoms but also interrupt disease progression and systemic inflammation.
Targeted intervention at the...
07/10/2025
The Dermatologist
psoriatic arthritis
News
IL-23 and IL-17 Inhibitors Linked to Lower Risk of Psoriatic Arthritis in Patients with Plaque Psoriasis
06/17/2025
Jessica Garlewicz
In patients at increased risk for PsA, IL-23 or IL-17 inhibitors may offer added benefit in mitigating progression to joint involvement.
In patients at increased risk for PsA, IL-23 or IL-17 inhibitors may offer added benefit in mitigating progression to joint involvement.
In patients at increased risk...
06/17/2025
The Dermatologist

Expert Insights

Celia Mead, Executive Director of BIRD
Q&As
Bath Institute for Rheumatic Diseases: Empowering Psoriatic Arthritis Researchers and Patients Alike
01/11/2022
Celia Mead
Celia Mead, executive director of BIRD, spoke about the organization's initiatives for psoriatic arthritis and other diseases after receiving the UPLIFT Innovation Challenge grant.
Celia Mead, executive director of BIRD, spoke about the organization's initiatives for psoriatic arthritis and other diseases after receiving the UPLIFT Innovation Challenge grant.
Celia Mead, executive director...
01/11/2022
The Dermatologist
Heberton
Videos
Managing EGFR Skin Toxicities
04/01/2026
Riya Gandhi, MA
This interview focuses on the most common EGFR inhibitor–associated skin adverse events, when they typically emerge, and practical strategies to reduce severity—including skincare routines, photoprotection, and prophylactic approaches.
This interview focuses on the most common EGFR inhibitor–associated skin adverse events, when they typically emerge, and practical strategies to reduce severity—including skincare routines, photoprotection, and prophylactic approaches.
This interview focuses on the...
04/01/2026
The Dermatologist
Amy paller
Videos
Disease Biology and Early Recognition in Atopic Dermatitis
04/01/2026
Amy S. Paller, MD, MS; Riya Gandhi, MA
Dr Amy Paller discusses how recognizing pediatric atopic dermatitis as a type 2 inflammatory disease has transformed early treatment strategies, enabling safer and more proactive use of targeted therapies.
Dr Amy Paller discusses how recognizing pediatric atopic dermatitis as a type 2 inflammatory disease has transformed early treatment strategies, enabling safer and more proactive use of targeted therapies.
Dr Amy Paller discusses how...
04/01/2026
The Dermatologist
Joseph F. Merola, MD, MMSc, and Colby Evans, MD
Videos
Autoimmune Serologies in Dermatology
04/01/2026
Riya Gandhi, MA
Dr Joseph Merola breaks down how dermatologists can accurately interpret autoimmune serologies, with a focus on ANA testing, clinical context, and avoiding unnecessary labs.
Dr Joseph Merola breaks down how dermatologists can accurately interpret autoimmune serologies, with a focus on ANA testing, clinical context, and avoiding unnecessary labs.
Dr Joseph Merola breaks down how...
04/01/2026
The Dermatologist
Melissa Mauskar, MD
Videos
Practical Pearls of Vulvar Dermatoses
04/01/2026
Riya Gandhi, MA
Dr Melissa Mauskar discusses common diagnostic pitfalls in vulvar dermatoses, including overlapping conditions and misdiagnosis of lichen sclerosus versus genitourinary syndrome of menopause.
Dr Melissa Mauskar discusses common diagnostic pitfalls in vulvar dermatoses, including overlapping conditions and misdiagnosis of lichen sclerosus versus genitourinary syndrome of menopause.
Dr Melissa Mauskar discusses...
04/01/2026
The Dermatologist
Guttman
Videos
Chronic Hand Eczema: Pathways and Emerging Therapies
04/01/2026
Riya Gandhi, MA
Dr Emma Guttman explains how chronic hand eczema is now understood as a heterogeneous disease driven by different immune pathways depending on underlying causes.
Dr Emma Guttman explains how chronic hand eczema is now understood as a heterogeneous disease driven by different immune pathways depending on underlying causes.
Dr Emma Guttman explains how...
04/01/2026
The Dermatologist
Elman
Videos
Baseline Screening and Monitoring for Biologics and Small Molecules
04/01/2026
Scott Andrew Elman, MD, FAAD; Riya Gandhi, MA
Are dermatologists overtesting patients on biologics and new oral therapies? Dr Scott Elman explains how mechanism-based screening can reduce unnecessary testing while maintaining patient safety.
Are dermatologists overtesting patients on biologics and new oral therapies? Dr Scott Elman explains how mechanism-based screening can reduce unnecessary testing while maintaining patient safety.
Are dermatologists overtesting...
04/01/2026
The Dermatologist
brad glick
Videos
Oral Therapies in Psoriasis
04/01/2026
Riya Gandhi, MA
Dr Brad Glick discusses persistent unmet needs in psoriasis care, including undertreatment, low systemic therapy adoption, and challenges in high-impact disease areas.
Dr Brad Glick discusses persistent unmet needs in psoriasis care, including undertreatment, low systemic therapy adoption, and challenges in high-impact disease areas.
Dr Brad Glick discusses...
04/01/2026
The Dermatologist
Videos
Hidradenitis Suppurativa: Early Recognition, IL-17 Targeted Therapies, and Multidisciplinary Care
04/01/2026
Riya Gandhi, MA
Dr Jack O’Brien discusses how dermatologists can reduce diagnostic delays in hidradenitis suppurativa by recognizing early clinical signs such as recurrent abscesses in intertriginous areas and associated acne.
Dr Jack O’Brien discusses how dermatologists can reduce diagnostic delays in hidradenitis suppurativa by recognizing early clinical signs such as recurrent abscesses in intertriginous areas and associated acne.
Dr Jack O’Brien discusses how...
04/01/2026
The Dermatologist
Asempa
Videos
Improving Dermatology Measures for Skin of Color and Underrepresented Groups
04/01/2026
Riya Gandhi, MA
This interview examines the limitations of commonly used dermatology outcome measures in patients with skin of color and other underrepresented populations.
This interview examines the limitations of commonly used dermatology outcome measures in patients with skin of color and other underrepresented populations.
This interview examines the...
04/01/2026
The Dermatologist
Orgill
Videos
Mohs Reconstruction Collaboration
04/01/2026
Riya Gandhi, MA
Dr Dennis Orgill discusses when dermatologists should involve plastic surgeons after Mohs surgery, particularly for complex defects in high-visibility areas such as the nose, eyes, and mouth.
Dr Dennis Orgill discusses when dermatologists should involve plastic surgeons after Mohs surgery, particularly for complex defects in high-visibility areas such as the nose, eyes, and mouth.
Dr Dennis Orgill discusses when...
04/01/2026
The Dermatologist

News

psoriatic arthritis
News
Rare Case Highlights Diagnostic and Treatment Challenges in PsA–Myopathy Overlap
09/02/2025
Jessica Garlewicz
The case study, accompanied by a review of 17 similar reports, details shared immunopathogenesis and conflicting treatment responses in this rare overlap syndrome.
The case study, accompanied by a review of 17 similar reports, details shared immunopathogenesis and conflicting treatment responses in this rare overlap syndrome.
The case study, accompanied by a...
09/02/2025
The Dermatologist
psoriatic arthritis
News
Real-World Data Support ITABIO Guidelines for Second-Line Biologic Use in Inflammatory Arthritis
09/02/2025
Jessica Garlewicz
The study evaluated treatment patterns and patient characteristics to assess the impact of these guidelines in real-world care.
The study evaluated treatment patterns and patient characteristics to assess the impact of these guidelines in real-world care.
The study evaluated treatment...
09/02/2025
The Dermatologist
psoriatic arthritis
News
TNF Inhibitors Improve Clinical Outcomes in csDMARD-Inadequate Psoriatic Arthritis, Review Finds
07/22/2025
Jessica Garlewicz
For practicing dermatologists, these findings reinforce current guidelines that position TNF inhibitors as a first-line biologic option for patients with active psoriatic arthritis.
For practicing dermatologists, these findings reinforce current guidelines that position TNF inhibitors as a first-line biologic option for patients with active psoriatic arthritis.
For practicing dermatologists,...
07/22/2025
The Dermatologist
psoriatic arthritis
News
IL-23/IL-17 Axis Central to Psoriatic Arthritis Pathogenesis, Study Finds
07/10/2025
Jessica Garlewicz
Targeted intervention at the level of the IL-23/IL-17 axis may not only control clinical symptoms but also interrupt disease progression and systemic inflammation.
Targeted intervention at the level of the IL-23/IL-17 axis may not only control clinical symptoms but also interrupt disease progression and systemic inflammation.
Targeted intervention at the...
07/10/2025
The Dermatologist
psoriatic arthritis
News
IL-23 and IL-17 Inhibitors Linked to Lower Risk of Psoriatic Arthritis in Patients with Plaque Psoriasis
06/17/2025
Jessica Garlewicz
In patients at increased risk for PsA, IL-23 or IL-17 inhibitors may offer added benefit in mitigating progression to joint involvement.
In patients at increased risk for PsA, IL-23 or IL-17 inhibitors may offer added benefit in mitigating progression to joint involvement.
In patients at increased risk...
06/17/2025
The Dermatologist
psoriatic arthritis
News
Emerging Imaging Technologies Offer New Precision in Psoriatic Arthritis Diagnosis and Management
06/03/2025
Jessica Garlewicz
Recent innovations have introduced imaging tools that assess not only structural abnormalities but also molecular and cellular activity, enabling earlier and more precise characterization of disease processes.
Recent innovations have introduced imaging tools that assess not only structural abnormalities but also molecular and cellular activity, enabling earlier and more precise characterization of disease processes.
Recent innovations have...
06/03/2025
The Dermatologist
psoriatic arthritis
News
Proteomic Advances Highlight Promising Biomarkers for Psoriatic Arthritis Diagnosis
05/20/2025
Jessica Garlewicz
A new review highlights the potential of proteomics to transform the diagnostic landscape for psoriatic arthritis.
A new review highlights the potential of proteomics to transform the diagnostic landscape for psoriatic arthritis.
A new review highlights the...
05/20/2025
The Dermatologist
psoriatic arthritis
News
Emerging Psoriasis and Psoriatic Arthritis Therapies Expand Treatment Landscape
04/29/2025
Jessica Garlewicz
For dermatologists, the continued emergence of new targeted therapies requires careful patient selection and vigilance regarding long-term safety.
For dermatologists, the continued emergence of new targeted therapies requires careful patient selection and vigilance regarding long-term safety.
For dermatologists, the...
04/29/2025
The Dermatologist
psoriatic arthritis
News
Updated Evidence Reinforces Efficacy and Safety of Pharmacologic Therapies in Psoriatic Arthritis
04/17/2025
Jessica Garlewicz
A new systematic literature review provides an updated overview of the efficacy and safety of pharmacologic treatments for psoriatic arthritis.
A new systematic literature review provides an updated overview of the efficacy and safety of pharmacologic treatments for psoriatic arthritis.
A new systematic literature...
04/17/2025
The Dermatologist
psoriatic arthritis
News
New Meta-Review Highlights Prevalence and Psychological Burden of Psoriatic Arthritis
04/01/2025
Jessica Garlewicz
A new overview of systematic reviews consolidates existing data on the global prevalence, incidence, and psychological comorbidities associated with psoriatic arthritis.
A new overview of systematic reviews consolidates existing data on the global prevalence, incidence, and psychological comorbidities associated with psoriatic arthritis.
A new overview of systematic...
04/01/2025
The Dermatologist
psoriasis0
News
Altered Lysine Crotonylation Identified in Psoriatic Skin
03/19/2026
Jessica Garlewicz
Lysine crotonylation, a post-translational modification previously studied in oncology, may play a role in psoriasis pathogenesis, according to a translational study comparing protein modification profiles in lesional and non-lesional skin.
Lysine crotonylation, a post-translational modification previously studied in oncology, may play a role in psoriasis pathogenesis, according to a translational study comparing protein modification profiles in lesional and non-lesional skin.
Lysine crotonylation, a...
03/19/2026
The Dermatologist
atopic dermatitis
News
Mixed Associations Between Socioeconomic Status and Pediatric Atopic Dermatitis Highlight Research Gaps
03/11/2026
Jessica Garlewicz
Socioeconomic status appears to influence pediatric atopic dermatitis, but the direction and strength of the association remain unclear.
Socioeconomic status appears to influence pediatric atopic dermatitis, but the direction and strength of the association remain unclear.
Socioeconomic status appears to...
03/11/2026
The Dermatologist
psoriasis
News
Biologic Therapy Improves Psychological Well-Being and Quality of Life in Psoriasis
03/03/2026
Jessica Garlewicz
Biologic therapy for moderate-to-severe plaque psoriasis was associated with marked improvements in psychological distress and quality of life in a real-world clinical setting.
Biologic therapy for moderate-to-severe plaque psoriasis was associated with marked improvements in psychological distress and quality of life in a real-world clinical setting.
Biologic therapy for...
03/03/2026
The Dermatologist
psoriasis
News
Low Prevalence but Meaningful Impact of Psychological Symptoms Seen in Well-Controlled Psoriasis
02/03/2026
Jessica Garlewicz
Anxiety and depression symptoms can still occur in young adults with well-controlled psoriasis, even when disease activity is minimal, according to a cross-sectional study exploring psychological distress and its potential biological...
Anxiety and depression symptoms can still occur in young adults with well-controlled psoriasis, even when disease activity is minimal, according to a cross-sectional study exploring psychological distress and its potential biological...
Anxiety and depression symptoms...
02/03/2026
The Dermatologist
psoriasis
News
Mathematical Modeling Study Highlights Cytokine Balance and Stem Cell Feedback in Psoriasis Control
01/22/2026
Jessica Garlewicz
A new systems biology study using mathematical modeling provides insight into how cytokine imbalance drives psoriasis flares and suggests that restoring immune-epidermal feedback.
A new systems biology study using mathematical modeling provides insight into how cytokine imbalance drives psoriasis flares and suggests that restoring immune-epidermal feedback.
A new systems biology study...
01/22/2026
The Dermatologist
Cutaneous Squamous Cell Carcinoma
News
Managing Cutaneous Squamous Cell Carcinoma
01/06/2026
Jessica Garlewicz
An updated evidence-based review outlines contemporary strategies for evaluating and managing cutaneous squamous cell carcinoma.
An updated evidence-based review outlines contemporary strategies for evaluating and managing cutaneous squamous cell carcinoma.
An updated evidence-based review...
01/06/2026
The Dermatologist
psoriatic arthritis
News
Rare Case Highlights Diagnostic and Treatment Challenges in PsA–Myopathy Overlap
09/02/2025
Jessica Garlewicz
The case study, accompanied by a review of 17 similar reports, details shared immunopathogenesis and conflicting treatment responses in this rare overlap syndrome.
The case study, accompanied by a review of 17 similar reports, details shared immunopathogenesis and conflicting treatment responses in this rare overlap syndrome.
The case study, accompanied by a...
09/02/2025
The Dermatologist
psoriatic arthritis
News
Real-World Data Support ITABIO Guidelines for Second-Line Biologic Use in Inflammatory Arthritis
09/02/2025
Jessica Garlewicz
The study evaluated treatment patterns and patient characteristics to assess the impact of these guidelines in real-world care.
The study evaluated treatment patterns and patient characteristics to assess the impact of these guidelines in real-world care.
The study evaluated treatment...
09/02/2025
The Dermatologist
psoriasis
News
Study Links Hypothyroidism to Psoriasis, Independent of Disease Severity
09/02/2025
Jessica Garlewicz
The findings suggest that thyroid abnormalities may represent an independent comorbidity, rather than a direct consequence of psoriasis severity.
The findings suggest that thyroid abnormalities may represent an independent comorbidity, rather than a direct consequence of psoriasis severity.
The findings suggest that...
09/02/2025
The Dermatologist
psoriasis
News
Beta-Blockers Not Linked to Increased Psoriasis Risk, Study Finds
09/02/2025
Jessica Garlewicz
A new multi-method analysis challenges long-standing concerns regarding beta-blockers and their role in triggering or worsening psoriasis.
A new multi-method analysis challenges long-standing concerns regarding beta-blockers and their role in triggering or worsening psoriasis.
A new multi-method analysis...
09/02/2025
The Dermatologist

Quiz

Patient with psoriasis and obesity. The effects of obesity can have a negative impact psoriasis and psoriatic arthritis.
Quiz
Trivia: Psoriatic Arthritis and Obesity
10/26/2021
Which of these options best describes the effects of obesity on patients with psoriatic arthritis?
Which of these options best describes the effects of obesity on patients with psoriatic arthritis?
Which of these options best...
10/26/2021
The Dermatologist
Patient with severe psoriasis on knees with a potential link to psoriatic arthritis and its differing oxylipin profile.
Quiz
Trivia: Oxylipin Profiles in PsA versus Psoriasis
09/16/2021
Can you identify the serum oxylipin profiles in patients with psoriatic arthritis and with psoriasis?
Can you identify the serum oxylipin profiles in patients with psoriatic arthritis and with psoriasis?
Can you identify the serum...
09/16/2021
The Dermatologist
Patient with severe psoriasis on their legs shares a risk factor and one inverse association with psoriatic arthritis.
Quiz
Trivia: Risk Factor and Inverse Association Between PsA, PsO, RA and AS
09/02/2021
Which of these options accurately identifies the one risk factor and one inverse association between psoriatic arthritis, psoriasis, rheumatoid arthritis, and ankylosing spondylitis?
Which of these options accurately identifies the one risk factor and one inverse association between psoriatic arthritis, psoriasis, rheumatoid arthritis, and ankylosing spondylitis?
Which of these options...
09/02/2021
The Dermatologist
Psoriasis on an elbow with the potential link to psoriatic arthritis showcasing the possibilities of psoriatic treatment.
Quiz
Trivia: Psoriatic Arthritis Risk With Skin Biologics
08/18/2021
Can you determine if the statement on psoriatic arthritis risks with skin biologics is true or false based on a study from Annals of the Rheumatic Diseases?
Can you determine if the statement on psoriatic arthritis risks with skin biologics is true or false based on a study from Annals of the Rheumatic Diseases?
Can you determine if the...
08/18/2021
The Dermatologist
Quiz
Trivia: Air Pollution and Chronic Inflammatory Arthritides
07/13/2021
Can you identify which of the following accurately showcases the results of a study aimed to determine the role of air pollutants on the biological treatment response of chronic inflammatory arthritides?
Can you identify which of the following accurately showcases the results of a study aimed to determine the role of air pollutants on the biological treatment response of chronic inflammatory arthritides?
Can you identify which of the...
07/13/2021
The Dermatologist
Quiz
True or False: High BMI Association with PsA
05/11/2021
Can you determine if the statement regarding BMI association with PsA is true or false?
Can you determine if the statement regarding BMI association with PsA is true or false?
Can you determine if the...
05/11/2021
The Dermatologist
Quiz
Relationship Between Adalimumab and Psoriatic Arthritis
04/07/2021
What is the relationship between adalimumab and disease activity in patients with psoriatic disease?
What is the relationship between adalimumab and disease activity in patients with psoriatic disease?
What is the relationship between...
04/07/2021
The Dermatologist
Quiz
Psoriatic Arthritis Diagnosis Delay
03/09/2021
Can you identify the patient group that is more susceptible to a delayed diagnosis for psoriatic arthritis?
Can you identify the patient group that is more susceptible to a delayed diagnosis for psoriatic arthritis?
Can you identify the patient...
03/09/2021
The Dermatologist
Quiz
Type 2 Inflammation and Early Systemic Therapy in Pediatric Atopic Dermatitis
04/05/2026
Riya Gandhi, MA
Assess advanced clinical reasoning in pediatric atopic dermatitis, including implications of type 2 inflammation for diagnosis, treatment timing, and systemic therapy decisions.
Assess advanced clinical reasoning in pediatric atopic dermatitis, including implications of type 2 inflammation for diagnosis, treatment timing, and systemic therapy decisions.
Assess advanced clinical...
04/05/2026
The Dermatologist
Quiz
Disease Heterogeneity in PN
03/15/2026
Riya Gandhi, MA
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of...
03/15/2026
The Dermatologist
Quiz
Rethinking Severity and JAK Inhibitor Strategy in Alopecia Areata
03/12/2026
Riya Gandhi, MA
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine...
03/12/2026
The Dermatologist
Quiz
Cytokine Hierarchy and Sustained Pruritus in PN
03/10/2026
Riya Gandhi, MA
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and...
03/10/2026
The Dermatologist
Quiz
Type 2 Inflammation as a Pathogenic Driver in Prurigo Nodularis
03/05/2026
Riya Gandhi, MA
Test your understanding of how type 2 immune signaling drives chronic itch in prurigo nodularis through complex neuroimmune interactions.
Test your understanding of how type 2 immune signaling drives chronic itch in prurigo nodularis through complex neuroimmune interactions.
Test your understanding of how...
03/05/2026
The Dermatologist
psoriasis
Quiz
Distinguishing Feature of Generalized Pustular Psoriasis
03/02/2026
Jessica Garlewicz
What is a key distinguishing feature of generalized pustular psoriasis that differentiates it from plaque psoriasis?
What is a key distinguishing feature of generalized pustular psoriasis that differentiates it from plaque psoriasis?
What is a key distinguishing...
03/02/2026
The Dermatologist
psoriasis
Quiz
Quiz: Misdiagnosis of Generalized Pustular Psoriasis
03/02/2026
Jessica Garlewicz
What is the reason generalized pustular psoriasis is often misdiagnosed?
What is the reason generalized pustular psoriasis is often misdiagnosed?
What is the reason generalized...
03/02/2026
The Dermatologist
Quiz
Allergic Disease Progression: Genetics and Environment
02/26/2026
Riya Gandhi, MA
Explore the relationship between allergic disease trends, genetic timelines, and the clinical framework used to describe the progression of atopic conditions across childhood.
Explore the relationship between allergic disease trends, genetic timelines, and the clinical framework used to describe the progression of atopic conditions across childhood.
Explore the relationship between...
02/26/2026
The Dermatologist
Quiz
Early Intervention Strategies in Pediatric Atopic Dermatitis
02/26/2026
Riya Gandhi, MA
Assess your understanding of early skin barrier interventions in infants and the clinical rationale for prompt treatment of atopic dermatitis in young children, including implications for long-term disease outcomes.
Assess your understanding of early skin barrier interventions in infants and the clinical rationale for prompt treatment of atopic dermatitis in young children, including implications for long-term disease outcomes.
Assess your understanding of...
02/26/2026
The Dermatologist
Quiz
Air Pollution and Atopic Disease: Evaluating Epidemiologic Evidence
02/26/2026
Riya Gandhi, MA
Test your knowledge of the epidemiologic data examining environmental exposures and their association with atopic disease development. This quiz explores key population-level observations shaping modern allergy research.
Test your knowledge of the epidemiologic data examining environmental exposures and their association with atopic disease development. This quiz explores key population-level observations shaping modern allergy research.
Test your knowledge of the...
02/26/2026
The Dermatologist
cover March 2026

Current Issue

March 2026
Volume 34
Issue 2
Current Issue
Issue Archive
The Dermatologist Newsletter

Recent News

psoriatic arthritis
News
Rare Case Highlights Diagnostic and Treatment Challenges in PsA–Myopathy Overlap
09/02/2025
Jessica Garlewicz
The case study, accompanied by a review of 17 similar reports, details shared immunopathogenesis and conflicting treatment responses in this rare overlap syndrome.
The case study, accompanied by a review of 17 similar reports, details shared immunopathogenesis and conflicting treatment responses in this rare overlap syndrome.
The case study, accompanied by a...
09/02/2025
The Dermatologist
psoriatic arthritis
News
Real-World Data Support ITABIO Guidelines for Second-Line Biologic Use in Inflammatory Arthritis
09/02/2025
Jessica Garlewicz
The study evaluated treatment patterns and patient characteristics to assess the impact of these guidelines in real-world care.
The study evaluated treatment patterns and patient characteristics to assess the impact of these guidelines in real-world care.
The study evaluated treatment...
09/02/2025
The Dermatologist
psoriatic arthritis
News
TNF Inhibitors Improve Clinical Outcomes in csDMARD-Inadequate Psoriatic Arthritis, Review Finds
07/22/2025
Jessica Garlewicz
For practicing dermatologists, these findings reinforce current guidelines that position TNF inhibitors as a first-line biologic option for patients with active psoriatic arthritis.
For practicing dermatologists, these findings reinforce current guidelines that position TNF inhibitors as a first-line biologic option for patients with active psoriatic arthritis.
For practicing dermatologists,...
07/22/2025
The Dermatologist
psoriatic arthritis
News
IL-23/IL-17 Axis Central to Psoriatic Arthritis Pathogenesis, Study Finds
07/10/2025
Jessica Garlewicz
Targeted intervention at the level of the IL-23/IL-17 axis may not only control clinical symptoms but also interrupt disease progression and systemic inflammation.
Targeted intervention at the level of the IL-23/IL-17 axis may not only control clinical symptoms but also interrupt disease progression and systemic inflammation.
Targeted intervention at the...
07/10/2025
The Dermatologist
psoriatic arthritis
News
IL-23 and IL-17 Inhibitors Linked to Lower Risk of Psoriatic Arthritis in Patients with Plaque Psoriasis
06/17/2025
Jessica Garlewicz
In patients at increased risk for PsA, IL-23 or IL-17 inhibitors may offer added benefit in mitigating progression to joint involvement.
In patients at increased risk for PsA, IL-23 or IL-17 inhibitors may offer added benefit in mitigating progression to joint involvement.
In patients at increased risk...
06/17/2025
The Dermatologist
psoriatic arthritis
News
Emerging Imaging Technologies Offer New Precision in Psoriatic Arthritis Diagnosis and Management
06/03/2025
Jessica Garlewicz
Recent innovations have introduced imaging tools that assess not only structural abnormalities but also molecular and cellular activity, enabling earlier and more precise characterization of disease processes.
Recent innovations have introduced imaging tools that assess not only structural abnormalities but also molecular and cellular activity, enabling earlier and more precise characterization of disease processes.
Recent innovations have...
06/03/2025
The Dermatologist
psoriatic arthritis
News
Proteomic Advances Highlight Promising Biomarkers for Psoriatic Arthritis Diagnosis
05/20/2025
Jessica Garlewicz
A new review highlights the potential of proteomics to transform the diagnostic landscape for psoriatic arthritis.
A new review highlights the potential of proteomics to transform the diagnostic landscape for psoriatic arthritis.
A new review highlights the...
05/20/2025
The Dermatologist
psoriatic arthritis
News
Emerging Psoriasis and Psoriatic Arthritis Therapies Expand Treatment Landscape
04/29/2025
Jessica Garlewicz
For dermatologists, the continued emergence of new targeted therapies requires careful patient selection and vigilance regarding long-term safety.
For dermatologists, the continued emergence of new targeted therapies requires careful patient selection and vigilance regarding long-term safety.
For dermatologists, the...
04/29/2025
The Dermatologist
psoriatic arthritis
News
Updated Evidence Reinforces Efficacy and Safety of Pharmacologic Therapies in Psoriatic Arthritis
04/17/2025
Jessica Garlewicz
A new systematic literature review provides an updated overview of the efficacy and safety of pharmacologic treatments for psoriatic arthritis.
A new systematic literature review provides an updated overview of the efficacy and safety of pharmacologic treatments for psoriatic arthritis.
A new systematic literature...
04/17/2025
The Dermatologist
psoriatic arthritis
News
New Meta-Review Highlights Prevalence and Psychological Burden of Psoriatic Arthritis
04/01/2025
Jessica Garlewicz
A new overview of systematic reviews consolidates existing data on the global prevalence, incidence, and psychological comorbidities associated with psoriatic arthritis.
A new overview of systematic reviews consolidates existing data on the global prevalence, incidence, and psychological comorbidities associated with psoriatic arthritis.
A new overview of systematic...
04/01/2025
The Dermatologist
psoriasis0
News
Altered Lysine Crotonylation Identified in Psoriatic Skin
03/19/2026
Jessica Garlewicz
Lysine crotonylation, a post-translational modification previously studied in oncology, may play a role in psoriasis pathogenesis, according to a translational study comparing protein modification profiles in lesional and non-lesional skin.
Lysine crotonylation, a post-translational modification previously studied in oncology, may play a role in psoriasis pathogenesis, according to a translational study comparing protein modification profiles in lesional and non-lesional skin.
Lysine crotonylation, a...
03/19/2026
The Dermatologist
FDA Alerts
FDA Approves Icotyde (icotrokinra) for the Treatment of Moderate-To-Severe Plaque Psoriasis in Adults and Pediatric Patients
03/18/2026
Jessica Garlewicz
The US Food and Drug Administration approved Icotyde (icotrokinra) for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients aged 12 years and older.
The US Food and Drug Administration approved Icotyde (icotrokinra) for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients aged 12 years and older.
The US Food and Drug...
03/18/2026
The Dermatologist
FDA Alerts
FDA Approves Cosentyx for the Treatment of Pediatric Patients Aged 12 Years and Older With Moderate-To-Severe Hidradenitis Suppurativa
03/17/2026
Jessica Garlewicz
The US Food and Drug Administration approved Cosentyx for the treatment of pediatric patients aged 12 years and older with moderate-to-severe hidradenitis suppurativa.
The US Food and Drug Administration approved Cosentyx for the treatment of pediatric patients aged 12 years and older with moderate-to-severe hidradenitis suppurativa.
The US Food and Drug...
03/17/2026
The Dermatologist
atopic dermatitis
News
Mixed Associations Between Socioeconomic Status and Pediatric Atopic Dermatitis Highlight Research Gaps
03/11/2026
Jessica Garlewicz
Socioeconomic status appears to influence pediatric atopic dermatitis, but the direction and strength of the association remain unclear.
Socioeconomic status appears to influence pediatric atopic dermatitis, but the direction and strength of the association remain unclear.
Socioeconomic status appears to...
03/11/2026
The Dermatologist
FDA Alerts
FDA Approves Sotyktu for the Treatment of Adults with Active Psoriatic Arthritis
03/10/2026
Jessica Garlewicz
On March 6, 2026, the US Food and Drug Administration approved Sotyktu (deucravacitinib) for the treatment of adults with active psoriatic arthritis.
On March 6, 2026, the US Food and Drug Administration approved Sotyktu (deucravacitinib) for the treatment of adults with active psoriatic arthritis.
On March 6, 2026, the US Food...
03/10/2026
The Dermatologist
psoriasis
News
Biologic Therapy Improves Psychological Well-Being and Quality of Life in Psoriasis
03/03/2026
Jessica Garlewicz
Biologic therapy for moderate-to-severe plaque psoriasis was associated with marked improvements in psychological distress and quality of life in a real-world clinical setting.
Biologic therapy for moderate-to-severe plaque psoriasis was associated with marked improvements in psychological distress and quality of life in a real-world clinical setting.
Biologic therapy for...
03/03/2026
The Dermatologist
psoriasis
News
Low Prevalence but Meaningful Impact of Psychological Symptoms Seen in Well-Controlled Psoriasis
02/03/2026
Jessica Garlewicz
Anxiety and depression symptoms can still occur in young adults with well-controlled psoriasis, even when disease activity is minimal, according to a cross-sectional study exploring psychological distress and its potential biological...
Anxiety and depression symptoms can still occur in young adults with well-controlled psoriasis, even when disease activity is minimal, according to a cross-sectional study exploring psychological distress and its potential biological...
Anxiety and depression symptoms...
02/03/2026
The Dermatologist
psoriasis
News
Mathematical Modeling Study Highlights Cytokine Balance and Stem Cell Feedback in Psoriasis Control
01/22/2026
Jessica Garlewicz
A new systems biology study using mathematical modeling provides insight into how cytokine imbalance drives psoriasis flares and suggests that restoring immune-epidermal feedback.
A new systems biology study using mathematical modeling provides insight into how cytokine imbalance drives psoriasis flares and suggests that restoring immune-epidermal feedback.
A new systems biology study...
01/22/2026
The Dermatologist
Cutaneous Squamous Cell Carcinoma
News
Managing Cutaneous Squamous Cell Carcinoma
01/06/2026
Jessica Garlewicz
An updated evidence-based review outlines contemporary strategies for evaluating and managing cutaneous squamous cell carcinoma.
An updated evidence-based review outlines contemporary strategies for evaluating and managing cutaneous squamous cell carcinoma.
An updated evidence-based review...
01/06/2026
The Dermatologist
Atopic dermatitis
FDA Alerts
FDA Approves Roflumilast Cream 0.05% for Treatment of Atopic Dermatitis in Children Aged 2 to 5
10/06/2025
Riya Gandhi, MA
On October 6, 2025, the US FDA approved ZORYVE (roflumilast) cream 0.05% for the topical treatment of mild-to-moderate atopic dermatitis in pediatric patients aged 2 to 5 years.
On October 6, 2025, the US FDA approved ZORYVE (roflumilast) cream 0.05% for the topical treatment of mild-to-moderate atopic dermatitis in pediatric patients aged 2 to 5 years.
On October 6, 2025, the US FDA...
10/06/2025
The Dermatologist

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use